Previous studies on PHOSPHO1 mainly focused on bone mineralization, while recent studies identified novel functions of PHOSPHO1 and its regulated phospholipid homeostasis on energy metabolism, which in turn serve as potential therapeutic candidates for the metabolic disorders, including obesity, T2D, and MAFLD. The gene discussed is PHOSPHO1; the disease is obesity due to melanocortin 4 receptor deficiency.